CURE RARE DISEASE INC
Balance Sheet
Fiscal Year Start:
Aug 1
Assets in 2024 (Year End)
$5,973,877
Property, Plant, & Equipment (net)
35%
Other Assets
30%
Cash & Equivalents
26%
Receivables (Non-Related)
6%
Prepaid Expenses
2%
Investments
1%
Related-Party Receivables
0%
Inventories
0%
Liabilities in 2024 (Year End)
$2,517,905
Notes Payable / Debt (Non-Related)
59%
Deferred Revenue
16%
Related-Party Payables
13%
Payables & Accruals
11%
Other Liabilities
1%
Grants Payable
0%
Tax-Exempt Bond Liabilities
0%
Custodial & Escrow Liabilities
0%
Assets
2023
2024
Change
Cash & Equivalents
$393,359
$1,552,885
+295%
Receivables (Non-Related)
$58,102
$350,718
+504%
Related-Party Receivables
$0
$0
-
Inventories
$0
$0
-
Prepaid Expenses
$38,812
$101,310
+161%
Investments
$314,779
$89,536
-72%
Property, Plant, & Equipment (net)
$2,111,098
$2,078,032
-2%
Other Assets
$361,417
$1,801,396
+398%
Total Assets
$3,277,567
$5,973,877
+82%
Liabilities
2023
2024
Change
Payables & Accruals
$322,460
$269,189
-17%
Grants Payable
-
-
-
Deferred Revenue
$88,801
$391,123
+340%
Tax-Exempt Bond Liabilities
-
-
-
Custodial & Escrow Liabilities
-
-
-
Notes Payable / Debt (Non-Related)
$1,476,508
$1,489,849
+1%
Related-Party Payables
$350,000
$338,887
-3%
Other Liabilities
$18,037
$28,857
+60%
Total Liabilities
$2,255,806
$2,517,905
+12%
Net assets
2023
2024
Change
Restricted Net Assets
$55,807
$333,474
+498%
Unrestricted Net Assets
$965,954
$3,122,498
+223%
Net assets
2023
2024
Change
Net assets
+$1,021,761
+$3,455,972
+238%
Copyright 2026. All rights reserved to Chario Inc. (d.b.a. Impala)